Letters of Intent (LOIs) Through the NCI’s Cancer Therapy Evaluation Program (CTEP) Dr. Patricia M. LoRusso, D.O. Karmanos Cancer Institute Wayne State.

Slides:



Advertisements
Similar presentations
The Drug Discovery Process
Advertisements

Before You Write APS Professional Skills Course: Writing and Reviewing for Scientific Journals.
1 FDA Industry Workshop Statistics in the FDA & Industry The Future David L DeMets, PhD Department of Biostatistics & Medical Informatics University of.
Department of Medicine Three Year Review Workshop Job Descriptions November 21, 2012 Joan Wither Co-Chair, Three Year Review Joan Wither Co-Chair, Three.
Department of Medicine Three Year Review Job Descriptions Job description should be defined when started in the Department of Medicine – last minute changes.
Single-Patient Use of Investigational Drugs and Biologic Products for Treating Cancer Grant Williams, M.D. Medical Team Leader DODP/CDER/FDA.
National Center for Research Resources NATIONAL INSTITUTES OF HEALTH T r a n s l a t i n g r e s e a r c h f r o m b a s i c d i s c o v e r y t o i m.
The Statisticians Role in Pharmaceutical Development
Role of the Statistician and the Bioinformatics Scientist in Cancer Clinical Trials Larry Rubinstein, PhD Biometric Research Branch, NCI International.
December 14, FDA Advisory Committee for Pharmaceutical Science Nonclinical Studies Subcommittee Efficient advancement to clinical trials Jack A.
What they never taught me about being a clinician investigator.
NSF Merit Review Criteria Revision Background. Established Spring 2010 Rationale: – More than 13 years since the last in-depth review and revision of.
1 Investigator-Initiated Clinical Research Planning, Developing, Conducting, Managing, and Succeeding Wm. Hirschhorn, M.S. Director, OCT & RQI and Adj.
An Overview of the NCI SBIR Program
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH Working with FDA: Biological Products and Clinical Development Critical Path.
Nanotechnology in Drug Discovery- Development and Delivery
How to get that first NIH grant
International Clinical Trials Dr. Luis A. Salicrup Senior International Cancer Research Specialist Center for Global Health National Cancer Institute National.
Getting Funded: How to write a good grant
Academic Clinical Trial Do’s & Don’ts for Partnering with Pharma CCAF San Diego, CA April 14, 2014 J. Eric Bubbers, Ph.D.
The Tools of Environmental Science
Nancy L Desmond, Ph.D. Division of Neuroscience & Basic Behavioral Science Key Things to Know about Research Project Grants (R01)
Dr Stewart Hay, CEO | | (03) www.therapeuticinnovation.com.au.
NCI Review of the Clinical Trials Process 6 th Annual National Forum on Biomedical Imaging in Oncology James H. Doroshow M.D. April 7, 2005 Bethesda, Maryland.
Bernard A Fox, PhD Immediate Past President and Chair, Executive Council Society for Immunotherapy of Cancer (SITC) Defining the Critical Hurdles in Cancer.
A Roadmap to Success Writing an Effective Research Grant Proposal Bob Miller, PhD Regents Professor Oklahoma State University 2011 Bob Miller, PhD Regents.
CTEP IND LOI Review and Approval Process. Study Proposals Letter of Intent May be sent in response to solicitation May be sent by investigator with interesting.
1 Introduction to Grant Writing Beth Virnig, PhD Haitao Chu, MD, PhD University of Minnesota, School of Public Health December 11, 2013.
Investigational Drugs in the hospital. + What is Investigational Drug? Investigational or experimental drugs are new drugs that have not yet been approved.
CTEP Protocol and Information Office (PIO) Overview.
How can we work together? Partnering with Industry: An Investigator’s Perspective Robert L. Coleman, MD M. D. Anderson Cancer Center.
PRE-PROPOSAL CONFERENCE JANUARY 31, ) All participants are in listen-in mode. 2) To ask a question, please type it into the Question box to the.
"Writing Successful Grant Proposals: Lessons Learned” Don W. Morgan Department of Health and Human Performance Center for Physical Activity and Health.
OMICS Group Contact us at: OMICS Group International through its Open Access Initiative is committed to make genuine and.
Proposal for End-of-Phase 2A (EOP2A) Meetings Advisory Committee for Pharmaceutical Sciences Clinical Pharmacology Subcommittee November 17-18, 2003 Lawrence.
Finding Campaign Prospects and Campaign Leadership March 17, 2003 © Tamarack – An Institute for Community Engagement & Wayne Hussey Consulting Inc
NFBIO: Update on NCI Imaging Activities Daniel C. Sullivan, M.D. Cancer Imaging Program, DCTD, NCI.
NIHR Research Design Service London Enabling Better Research Dr Caroline Burgess General Adviser 13 th November 2013.
Team Building: Critical Role of Interdisciplinary Research Teams in Translational Research C. Kent Osborne, M.D. Director, Lester and Sue Smith Breast.
Initiating phase 1 clinical trials in pediatric oncology National Cancer Institute Perspective Barry Anderson, MD, PhD Pediatric Section Cancer Therapy.
Translation and Innovation Mark Chance, PhD Vice Dean for Research School of Medicine October 19, 2015.
First Annual Meeting. Project Development Teams: Concept and Example Scott C. Denne, M.D. Professor of Pediatrics Associate Director of the Indiana CTSI.
1Mobile Computing Systems © 2001 Carnegie Mellon University Writing a Successful NSF Proposal November 4, 2003 Website: nsf.gov.
Robert H. Wiltrout Director, CCR Director’s Address.
Role of the Drug Project Team in Formulating the Initial Development Plan of NCI-IND agents Jeff Moscow, MD IDB, CTEP.
Open to all: the role of public involvement in health research Faculty of Health and Social Care, Open University, Wednesday 9 th December 2015 Simon Denegri,
Ronald Margolis, Ph.D. National Institute of Diabetes, Digestive and Kidney Diseases Amanda Boyce, Ph.D. National Institute of Arthritis and Musculoskeletal.
How Research Gets Funded A report by Wayne Wakeland from a workshop given at PSU in late Sept. ’06 by The Grant Institute.
CTEP Visiting Physician Externship Coordinator: Igor Espinoza-Delgado, M.D. NCI CTEP Investigational Drug Branch
1 Grant Applications Rachel Croson, PhD Dean, College of Business UT Arlington (formerly DD SES/SBE NSF)
Pilot Grant Program EGAD Study OCCUPATIONAL & ENVIRONMENTAL HEALTH.
AuthorAID Workshop on Proposal Writing Rwanda June 2011.
Startup Name Business Plan v.1. Problem/solution Tell a story, be creative, help investors understand the pain and why the solution is needed If investors.
Foundation Doctors’ Academic Meeting Kathryn Adcock Wellcome Trust March 2011.
NoWCADD Progress Report 2015
Institutional Development Award (IDeA) Program – Infrastructure for Clinical and Translational Research (IDeA-CTR) J. Rafael Gorospe M.D. Ph.D. Medical.
R01? R03? R21? How to choose the right funding mechanism Thomas Mitchell, MPH Department of Epidemiology & Biostatistics University of California San Francisco.
UoM/MRC Confidence in Concept
Translational Research Why should you care about translational research? The public cares. Translation into therapies justifies spending on science.
AACR Genomics In Clinical Medicine Think Tank
MRC’s Translational Research Funding
Thomas Mitchell, MA, MPH Department of Epidemiology & Biostatistics
OMICS Journals are welcoming Submissions
Helpful Hints & Fatal Flaws
Helpful Hints & Fatal Flaws
From Bench to Clinical Applications: Money Talks
Speeding access to therapies
Technical Communication: Strategies for College and the Workplace by Dan Jones & Karen Lane Chapter 16 Proposals Copyright © 2002 by Pearson Education,
Gynecologic Cancer Committee Clinical Trial Development
Thomas Mitchell, MA, MPH Department of Epidemiology & Biostatistics
Presentation transcript:

Letters of Intent (LOIs) Through the NCI’s Cancer Therapy Evaluation Program (CTEP) Dr. Patricia M. LoRusso, D.O. Karmanos Cancer Institute Wayne State University

Benefits of the CTEP LOI Allows investigators to perform clinical instead of clinical Allows investigators to perform clinical research instead of clinical trials Allows access to exciting novel agents Allows access to exciting novel agents Potential for novel-novel combination Potential for novel-novel combination Potential combinations from different companies Potential combinations from different companies CTEP holds the IND, less paperwork CTEP holds the IND, less paperwork Novel trial designs Novel trial designs Investigator initiated studies important for CCSGs Investigator initiated studies important for CCSGs Successful competition attractive to funding agencies Successful competition attractive to funding agencies

The NCI-CTEP LOI Required to conduct clinical trial with CTEP IND agents Required to conduct clinical trial with CTEP IND agents Solicited - submitted in response to development plan designed by CTEP Investigational Drug Steering Committee (IDSC) and industry collaborator Solicited - submitted in response to development plan designed by CTEP Investigational Drug Steering Committee (IDSC) and industry collaborator Unsolicited - submitted to address novel hypotheses supported by published or unpublished preclinical data Unsolicited - submitted to address novel hypotheses supported by published or unpublished preclinical data

Correlative Studies Correlative studies provide a better understanding of the effects of agents on their tumor targets Correlative studies provide a better understanding of the effects of agents on their tumor targets Pharmacokinetics Pharmacokinetics Pharmacodynamics Pharmacodynamics Pharmacogenetics Pharmacogenetics Biomarker analyses Biomarker analyses Molecular Profiling Molecular Profiling Each correlate should include rationale, hypothesis, and methods Each correlate should include rationale, hypothesis, and methods

Tips for a successful LOI START EARLY AND GIVE YOURSELF ENOUGH TIME!! START EARLY AND GIVE YOURSELF ENOUGH TIME!! Gather a team to help in design: Gather a team to help in design: clinicians clinicians scientists scientists statisticians statisticians budgetary specialists budgetary specialists Design aims / hypotheses in conjunction with a biostatistician Design aims / hypotheses in conjunction with a biostatistician Consider funding – if approved, is there $ to actually carry out the work? Consider funding – if approved, is there $ to actually carry out the work? Remember quality is the key – not quantity Remember quality is the key – not quantity

The Value of Partnerships Collaboration with other institutions allows: Collaboration with other institutions allows: Better science Better science Increased patient recruitment Increased patient recruitment Intellectual input Intellectual input Momentum Momentum

More tips Don’t be afraid to think outside the box!!! Don’t be afraid to think outside the box!!! Be creative Be creative Schedule meetings far in advance Schedule meetings far in advance Be mindful of the deadline Be mindful of the deadline Don’t be on an island – ask for help! Don’t be on an island – ask for help! CTEP is there to help you!!!!! CTEP is there to help you!!!!!

What I HATE about writing an LOI It takes a lot of time to write It takes a lot of time to write It competes with other commitments It competes with other commitments You don’t always get them!!!! You don’t always get them!!!! It is critical to learn from your failures!!!! It is critical to learn from your failures!!!!

What I LOVE about writing an LOI Creative fun Creative fun Allows translation of the science Allows translation of the science Allows collaboration Allows collaboration Leadership, negotiation and organization Leadership, negotiation and organization Helps organize and focus concepts Helps organize and focus concepts Often can lead to grant funding Often can lead to grant funding Exciting Exciting

The beauty of this process is to allow you to perform clinical instead of simply clinical The beauty of this process is to allow you to perform clinical research instead of simply clinical trials

Thank you!